Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT01795313
Title Immunotherapy for Recurrent Ependymomas in Children Treatment for Recurrent Ependymomas Using HLA-A2 Restricted Tumor Antigen Peptides in Combination With Imiquimod
Recruitment Recruiting
Gender both
Phase Phase 0
Variant Requirements No
Sponsors Ian F. Pollack, M.D.

malignant ependymoma


HLA-A2 restricted synthetic peptide vaccine + Imiquimod

Age Groups: adult child

No variant requirements are available.